Local view for "http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB08816"

PredicateValue (sorted: default)
rdfs:label
"Ticagrelor"
rdf:type
drugbank:drugs
drugbank:description
"Ticagrelor (trade name Brilinta in the US, Brilique and Possia in the EU) is a platelet aggregation inhibitor produced by AstraZeneca. Unlike clopidogrel, ticagrelor is not a prodrug and does not require metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010. The drug was approved by the US Food and Drug Administration on July 20, 2011."
drugbank:drugCategory
drugcategory:Platelet Aggregation Inhibitors
drugbank:interactsWith
drug:Lovastatin
drug:Simvastatin
drug:Conivaptan
drug:Etravirine
drug:Lomitapide
owl:sameAs
drug:Lovastatin
drug:Simvastatin
drug:Conivaptan
drug:Etravirine
drug:Lomitapide

All properties reside in the graph file:///home/swish/src/ClioPatria/guidelines3/drugbank_small.nt

The resource appears as object in 10 triples

Context graph